Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Pharmaceutical Preparations × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Recurrence 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Neoplasms 1 NSCLC 1 Myeloproliferative Disorders 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma 1 Lymphedema 1 Immunoglobulin Light-chain Amyloidosis 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Glioblastoma 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Dysplastic Nevus Syndrome 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 BRAF V600 Colorectal Cancer 1 Anxiety Disorders 1

Interventions

Cyclophosphamide 46 fludarabine 29 Rituximab 28 Doxorubicin 13 Prednisone 12 Magnetic Resonance Spectroscopy 12 fludarabine phosphate 11 Vincristine 11 Specimen Handling 11 Bendamustine Hydrochloride 10 pirtobrutinib 9 Lenalidomide 9 Etoposide 9 Biopsy 8 pembrolizumab 7 obinutuzumab 7 zanubrutinib 6 venetoclax 6 polatuzumab vedotin 5 glofitamab 5 Leukapheresis 5 Immunotherapy, Adoptive 5 tazemetostat 4 tafasitamab 4 ibrutinib 4 etoposide phosphate 4 Nivolumab 4 Injections 4 CT-P10 4 loncastuximab tesirine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡